sales@fnfresearch.comTel: +86 21 80360450 | USA: +1-347-989-3985

Search Market Research Report

Home / Medical Device / Wearable Injectors

Wearable Injectors Market By Type (On-Body Injectors and Off-Body Injectors), By Therapeutic Application (Immuno-Oncology, Cardiovascular Diseases, and Diabetes), and By End-User (Hospitals, Home Care Settings, and Clinics): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 – 2027

  • Publish On: Nov-2019
  • Total Pages: 110
  • Report Code: FAF-88
  • Base Year: 2018
  • Format:

Industry Insights

The report covers the forecast and analysis of the wearable injectors market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2027 based on revenue (USD Million). The study includes drivers and restraints of the wearable injectors market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the wearable injectors market on a global level.

In order to give the users of this report a comprehensive view of the treasury software market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product & service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the wearable injectors market by segmenting the market based on the type, therapeutic application, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2027. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The introduction of new technologies for maintaining the balance between disease management and lifestyles will impel the business growth during the forecast timeline. Moreover, technology has minimized the device size and made it user-friendly, thereby further spurring the expansion of the industry over the forecast timeline. Nonetheless, growing acceptance of alternate modes of drug delivery will inhibit the scope of the market during the forecast timeframe.

Based on the type, the market for wearable injectors is divided into On-Body Injectors and Off-Body Injectors. In terms of therapeutic application, the industry is sectored into Immuno-Oncology, Cardiovascular Diseases, and Diabetes. On the basis of end-user, the market is classified into Hospitals, Home Care Settings, and Clinics.

Global Wearable Injectors : Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Key Features of Wearable Injectors Report:

  • Wearable Injectors structure: Overview, industry life cycle analysis, supply chain analysis
  • Wearable Injectors : Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • Wearable Injectors size, trend, and forecast analysis
  • Wearable Injectors segments’ trend and forecast
  • Wearable Injectors ’s competitive landscapes: Market share, Product portfolio, New product launches, etc.
  • Wearable Injectors attractiveness and associated growth opportunities
  • Emerging trends in the Wearable Injectors .
  • Strategic growth opportunities for the existing and new players
  • Key success factors

Benefits of Buying from Facts & Factors:

  • Our proven methodologies and systematic analysis help in making confident business and strategic decisions.
  • A market study that conducts at Facts & Factors Market Research can save significant cost and time, and can help prevent making costly mistakes.

Table of Content

  • Chapter 1. Executive Summary 21
  • Chapter 2. Wearable Injectors market - Type Analysis 24
    • 2.1. Global Wearable Injectors Market - Type Overview 24
    • 2.2. Global Wearable Injectors Market Share, by Type, 2018 & 2025 (USD Million) 24
    • 2.3. On-Body Injectors 26
      • 2.3.1. Global On-Body Injectors Wearable Injectors Market, 2015-2027 (USD Million) 26
    • 2.4. Off-Body Injectors 27
      • 2.4.1. Global Off-Body Injectors Wearable Injectors Market, 2015-2027 (USD Million) 27
  • Chapter 3. Wearable Injectors market - Therapeutic Application Analysis 27
    • 3.1. Global Wearable Injectors Market - Therapeutic Application Overview 27
    • 3.2. Global Wearable Injectors Market Share, by Therapeutic Application, 2018 & 2025 (USD Million) 28
    • 3.3. Immuno-Oncology 29
      • 3.3.1. Global Immuno-Oncology Wearable Injectors Market, 2015-2027 (USD Million) 29
    • 3.4. Cardiovascular Diseases 30
      • 3.4.1. Global Cardiovascular Diseases Wearable Injectors Market, 2015-2027 (USD Million) 30
    • 3.5. Diabetes 31
      • 3.5.1. Global Diabetes Wearable Injectors Market, 2015-2027 (USD Million) 31
  • Chapter 4. Wearable Injectors market - End-User Analysis 31
    • 4.1. Global Wearable Injectors Market - End-User Overview 31
    • 4.2. Global Wearable Injectors Market Share, by End-User, 2018 & 2025 (USD Million) 32
    • 4.3. Hospitals 33
      • 4.3.1. Global Hospitals Wearable Injectors Market, 2015-2027 (USD Million) 33
    • 4.4. Home Care Settings 34
      • 4.4.1. Global Home Care Settings Wearable Injectors Market, 2015-2027 (USD Million) 34
    • 4.5. Clinics 35
      • 4.5.1. Global Clinics Wearable Injectors Market, 2015-2027 (USD Million) 35
  • Chapter 5. Wearable Injectors market - Regional Analysis 36
    • 5.1. Global Wearable Injectors Market Regional Overview 36
    • 5.2. Global Wearable Injectors Market Share, by Region, 2018 & 2025 (Value) 36
    • 5.3. North America 38
      • 5.3.1. North America Wearable Injectors Market size and forecast, 2015-2027 38
      • 5.3.2. North America Wearable Injectors Market, by Country, 2018 & 2025 (USD Million) 38
      • 5.3.3. North America Wearable Injectors Market, by Type, 2015-2027 40
        • 5.3.3.1. North America Wearable Injectors Market, by Type, 2015-2027 (USD Million) 40
      • 5.3.4. North America Wearable Injectors Market, by Therapeutic Application, 2015-2027 41
        • 5.3.4.1. North America Wearable Injectors Market, by Therapeutic Application, 2015-2027 (USD Million) 41
      • 5.3.5. North America Wearable Injectors Market, by End-User, 2015-2027 42
        • 5.3.5.1. North America Wearable Injectors Market, by End-User, 2015-2027 (USD Million) 42
      • 5.3.6. U.S. 43
        • 5.3.6.1. U.S. Market size and forecast, 2015-2027 (USD Million) 43
      • 5.3.7. Canada 44
        • 5.3.7.1. Canada Market size and forecast, 2015-2027 (USD Million) 44
      • 5.3.8. Mexico 45
        • 5.3.8.1. Mexico Market size and forecast, 2015-2027 (USD Million) 45
    • 5.4. Europe 46
      • 5.4.1. Europe Wearable Injectors Market size and forecast, 2015-2027 46
      • 5.4.2. Europe Wearable Injectors Market, by Country, 2018 & 2025 (USD Million) 46
      • 5.4.3. Europe Wearable Injectors Market, by Type, 2015-2027 48
        • 5.4.3.1. Europe Wearable Injectors Market, by Type, 2015-2027 (USD Million) 48
      • 5.4.4. Europe Wearable Injectors Market, by Therapeutic Application, 2015-2027 49
        • 5.4.4.1. Europe Wearable Injectors Market, by Therapeutic Application, 2015-2027 (USD Million) 49
      • 5.4.5. Europe Wearable Injectors Market, by End-User, 2015-2027 50
        • 5.4.5.1. Europe Wearable Injectors Market, by End-User, 2015-2027 (USD Million) 50
      • 5.4.6. Germany 51
        • 5.4.6.1. Germany Market size and forecast, 2015-2027 (USD Million) 51
      • 5.4.7. France 52
        • 5.4.7.1. France Market size and forecast, 2015-2027 (USD Million) 52
      • 5.4.8. U.K. 53
        • 5.4.8.1. U.K. Market size and forecast, 2015-2027 (USD Million) 53
      • 5.4.9. Italy 54
        • 5.4.9.1. Italy Market size and forecast, 2015-2027 (USD Million) 54
      • 5.4.10. Spain 55
        • 5.4.10.1. Spain Market size and forecast, 2015-2027 (USD Million) 55
      • 5.4.11. Nordic Countries 56
        • 5.4.11.1. Nordic Countries Market size and forecast, 2015-2027 (USD Million) 56
      • 5.4.12. Benelux Union 57
        • 5.4.12.1. Benelux Union Market size and forecast, 2015-2027 (USD Million) 57
      • 5.4.13. Rest of Europe 58
        • 5.4.13.1. Rest of Europe Market size and forecast, 2015-2027 (USD Million) 58
    • 5.5. Asia Pacific 59
      • 5.5.1. Asia Pacific Wearable Injectors Market size and forecast, 2015-2027 59
      • 5.5.2. Asia Pacific Wearable Injectors Market, by Country, 2018 & 2025 (USD Million) 59
      • 5.5.3. Asia Pacific Wearable Injectors Market, by Type, 2015-2027 61
        • 5.5.3.1. Asia Pacific Wearable Injectors Market, by Type, 2015-2027 (USD Million) 61
      • 5.5.4. Asia Pacific Wearable Injectors Market, by Therapeutic Application, 2015-2027 62
        • 5.5.4.1. Asia Pacific Wearable Injectors Market, by Therapeutic Application, 2015-2027 (USD Million) 62
      • 5.5.5. Asia Pacific Wearable Injectors Market, by End-User, 2015-2027 63
        • 5.5.5.1. Asia Pacific Wearable Injectors Market, by End-User, 2015-2027 (USD Million) 63
      • 5.5.6. China 64
        • 5.5.6.1. China Market size and forecast, 2015-2027 (USD Million) 64
      • 5.5.7. Japan 65
        • 5.5.7.1. Japan Market size and forecast, 2015-2027 (USD Million) 65
      • 5.5.8. India 66
        • 5.5.8.1. India Market size and forecast, 2015-2027 (USD Million) 66
      • 5.5.9. New Zealand 67
        • 5.5.9.1. New Zealand Market size and forecast, 2015-2027 (USD Million) 67
      • 5.5.10. Australia 68
        • 5.5.10.1. Australia Market size and forecast, 2015-2027 (USD Million) 68
      • 5.5.11. South Korea 69
        • 5.5.11.1. South Korea Market size and forecast, 2015-2027 (USD Million) 69
      • 5.5.12. South-East Asia 70
        • 5.5.12.1. South-East Asia Market size and forecast, 2015-2027 (USD Million) 70
      • 5.5.13. Rest of Asia Pacific 71
        • 5.5.13.1. Rest of Asia Pacific Market size and forecast, 2015-2027 (USD Million) 71
    • 5.6. Latin America 72
      • 5.6.1. Latin America Wearable Injectors Market size and forecast, 2015-2027 72
      • 5.6.2. Latin America Wearable Injectors Market, by Country, 2018 & 2025 (USD Million) 72
      • 5.6.3. Latin America Wearable Injectors Market, by Type, 2015-2027 74
      • 5.6.3.1. Latin America Wearable Injectors Market, by Type, 2015-2027 (USD Million) 74
      • 5.6.4. Latin America Wearable Injectors Market, by Therapeutic Application, 2015-2027 75
      • 5.6.4.1. Latin America Wearable Injectors Market, by Therapeutic Application, 2015-2027 (USD Million) 75
      • 5.6.5. Latin America Wearable Injectors Market, by End-User, 2015-2027 76
      • 5.6.5.1. Latin America Wearable Injectors Market, by End-User, 2015-2027 (USD Million) 76
      • 5.6.6. Brazil 77
        • 5.6.6.1. Brazil Market size and forecast, 2015-2027 (USD Million) 77
      • 5.6.7. Argentina 78
        • 5.6.7.1. Argentina Market size and forecast, 2015-2027 (USD Million) 78
      • 5.6.8. Rest of Latin America 79
        • 5.6.8.1. Rest of Latin America Market size and forecast, 2015-2027 (USD Million) 79
    • 5.7. The Middle-East and Africa 80
      • 5.7.1. The Middle-East and Africa Wearable Injectors Market size and forecast, 2015-2027 80
      • 5.7.2. The Middle-East and Africa Wearable Injectors Market, by Country, 2018 & 2025 (USD Million) 80
      • 5.7.3. The Middle-East and Africa Wearable Injectors Market, by Type, 2015-2027 82
        • 5.7.3.1. The Middle-East and Africa Wearable Injectors Market, by Type, 2015-2027 (USD Million) 82
      • 5.7.4. The Middle-East and Africa Wearable Injectors Market, by Therapeutic Application, 2015-2027 83
        • 5.7.4.1. The Middle-East and Africa Wearable Injectors Market, by Therapeutic Application, 2015-2027 (USD Million) 83
      • 5.7.5. The Middle-East and Africa Wearable Injectors Market, by End-User, 2015-2027 84
        • 5.7.5.1. The Middle-East and Africa Wearable Injectors Market, by End-User, 2015-2027 (USD Million) 84
      • 5.7.6. Saudi Arabia 85
        • 5.7.6.1. Saudi Arabia Market size and forecast, 2015-2027 (USD Million) 85
      • 5.7.7. UAE 86
        • 5.7.7.1. UAE Market size and forecast, 2015-2027 (USD Million) 86
      • 5.7.8. Egypt 87
        • 5.7.8.1. Egypt Market size and forecast, 2015-2027 (USD Million) 87
      • 5.7.9. Kuwait 88
        • 5.7.9.1. Kuwait Market size and forecast, 2015-2027 (USD Million) 88
      • 5.7.10. South Africa 89
        • 5.7.10.1. South Africa Market size and forecast, 2015-2027 (USD Million) 89
      • 5.7.11. Rest of Middle-East Africa 90
        • 5.7.11.1. Rest of Middle-East Africa Market size and forecast, 2015-2027 (USD Million) 90
  • Chapter 6. Wearable Injectors market - Competitive Landscape 91
    • 6.1. Competitor Market Share - Revenue 91
    • 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players 93
    • 6.3. Strategic Development 94
      • 6.3.1. Acquisitions and Mergers 94
      • 6.3.2. New Products 94
      • 6.3.3. Research & Development Activities 94
  • Chapter 7. Company Profiles 95
    • 7.1. Amgen 95
      • 7.1.1. Company Overview 95
      • 7.1.2. Amgen Revenue and Gross Margin 95
      • 7.1.3. Product portfolio 96
      • 7.1.4. Recent initiatives 97
    • 7.2. Becton 97
      • 7.2.1. Company Overview 97
      • 7.2.2. Becton Revenue and Gross Margin 97
      • 7.2.3. Product portfolio 98
      • 7.2.4. Recent initiatives 99
    • 7.3. Dickinson and Company 99
      • 7.3.1. Company Overview 99
      • 7.3.2. Dickinson and Company Revenue and Gross Margin 99
      • 7.3.3. Product portfolio 100
      • 7.3.4. Recent initiatives 101
    • 7.4. United Therapeutics Corporation 101
      • 7.4.1. Company Overview 101
      • 7.4.2. United Therapeutics Corporation Revenue and Gross Margin 101
      • 7.4.3. Product portfolio 102
      • 7.4.4. Recent initiatives 103
    • 7.5. Steadymed Therapeutics 103
      • 7.5.1. Company Overview 103
      • 7.5.2. Steadymed Therapeutics Revenue and Gross Margin 103
      • 7.5.3. Product portfolio 104
      • 7.5.4. Recent initiatives 105
    • 7.6. Tandem Diabetes Care Inc. 105
      • 7.6.1. Company Overview 105
      • 7.6.2. Tandem Diabetes Care Inc. Revenue and Gross Margin 105
      • 7.6.3. Product portfolio 106
      • 7.6.4. Recent initiatives 107
    • 7.7. Medtronic PLC 107
      • 7.7.1. Company Overview 107
      • 7.7.2. Medtronic PLC Revenue and Gross Margin 107
      • 7.7.3. Product portfolio 108
      • 7.7.4. Recent initiatives 109
    • 7.8. Valeritas Inc. 109
      • 7.8.1. Company Overview 109
      • 7.8.2. Valeritas Inc. Revenue and Gross Margin 109
      • 7.8.3. Product portfolio 110
      • 7.8.4. Recent initiatives 111
    • 7.9. Insulet Corporation 111
      • 7.9.1. Company Overview 111
      • 7.9.2. Insulet Corporation Revenue and Gross Margin 111
      • 7.9.3. Product portfolio 112
      • 7.9.4. Recent initiatives 113
    • 7.10. Ypsomed 113
      • 7.10.1. Company Overview 113
      • 7.10.2. Ypsomed Revenue and Gross Margin 113
      • 7.10.3. Product portfolio 114
      • 7.10.4. Recent initiatives 115
    • 7.11. Enable Injections 115
      • 7.11.1. Company Overview 115
      • 7.11.2. Enable Injections Revenue and Gross Margin 115
      • 7.11.3. Product portfolio 116
      • 7.11.4. Recent initiatives 117
    • 7.12. Sensile Medical 117
      • 7.12.1. Company Overview 117
      • 7.12.2. Sensile Medical Revenue and Gross Margin 117
      • 7.12.3. Product portfolio 118
      • 7.12.4. Recent initiatives 119
  • Chapter 8. Wearable Injectors ' Industry Analysis 120
    • 8.1. Wearable Injectors Market - Key Trends 120
      • 8.1.1. Market Drivers 121
      • 8.1.2. Market Restraints 121
      • 8.1.3. Market Opportunities 122
    • 8.2. Value Chain Analysis 123
    • 8.3. Technology Roadmap and Timeline 124
    • 8.4. Wearable Injectors Market - Attractiveness Analysis 125
      • 8.4.1. By Type 125
      • 8.4.2. By Therapeutic Application 125
      • 8.4.3. By End-User 126
      • 8.4.4. By Region 128
  • Chapter 9. Marketing Strategy Analysis, Distributors 129
    • 9.1. Marketing Channel 129
    • 9.2. Direct Marketing 130
    • 9.3. Indirect Marketing 130
    • 9.4. Marketing Channel Development Trend 130
    • 9.5. Economic/Political Environmental Change 131
  • Chapter 10. Report Conclusion 132
  • Chapter 11. Research Approach & Methodology 133
    • 11.1. Report Description 133
    • 11.2. Research Scope 134
    • 11.3. Research Methodology 134
      • 11.3.1. Secondary Research 135
      • 11.3.2. Primary Research 136
      • 11.3.3. Models 137
        • 11.3.3.1. Company Share Analysis Model 137
        • 11.3.3.2. Revenue Based Modeling 138
        • 11.3.3.3. Research Limitations 138

List of Figures

FIG. 1 Global Wearable Injectors Market, 2015-2027 (USD Million) 23
FIG. 2 Global Wearable Injectors Market Share, by Type, 2018 & 2025 (USD Million) 24
FIG. 3 Global On-Body Injectors Wearable Injectors Market, 2015-2027 (USD Million) 26
FIG. 4 Global Off-Body Injectors Wearable Injectors Market, 2015-2027 (USD Million) 27
FIG. 5 Global Wearable Injectors Market Share, by Therapeutic Application, 2018 & 2025 (USD Million) 28
FIG. 6 Global Immuno-Oncology Wearable Injectors Market, 2015-2027 (USD Million) 29
FIG. 7 Global Cardiovascular Diseases Wearable Injectors Market, 2015-2027 (USD Million) 30
FIG. 8 Global Diabetes Wearable Injectors Market, 2015-2027 (USD Million) 31
FIG. 9 Global Wearable Injectors Market Share, by End-User, 2018 & 2025 (USD Million) 32
FIG. 10 Global Hospitals Wearable Injectors Market, 2015-2027 (USD Million) 33
FIG. 11 Global Home Care Settings Wearable Injectors Market, 2015-2027 (USD Million) 34
FIG. 12 Global Clinics Wearable Injectors Market, 2015-2027 (USD Million) 35
FIG. 13 Global Wearable Injectors Market Share, by Region, 2018 & 2025 36
FIG. 14 North America Wearable Injectors Market, 2015-2027 38
FIG. 15 U.S. Wearable Injectors Market, 2015-2027 43
FIG. 16 Canada Wearable Injectors Market, 2015-2027 44
FIG. 17 Mexico Wearable Injectors Market, 2015-2027 45
FIG. 18 Europe Wearable Injectors Market, 2015-2027 46
FIG. 19 Germany Wearable Injectors Market, 2015-2027 51
FIG. 20 France Wearable Injectors Market, 2015-2027 52
FIG. 21 U.K. Wearable Injectors Market, 2015-2027 53
FIG. 22 Italy Wearable Injectors Market, 2015-2027 54
FIG. 23 Spain Wearable Injectors Market, 2015-2027 55
FIG. 24 Nordic Countries Wearable Injectors Market, 2015-2027 56
FIG. 25 Benelux Union Wearable Injectors Market, 2015-2027 57
FIG. 26 Rest of Europe Wearable Injectors Market, 2015-2027 58
FIG. 27 Asia Pacific Wearable Injectors Market, 2015-2027 59
FIG. 28 China Wearable Injectors Market, 2015-2027 64
FIG. 29 Japan Wearable Injectors Market, 2015-2027 65
FIG. 30 India Wearable Injectors Market, 2015-2027 66
FIG. 31 New Zealand Wearable Injectors Market, 2015-2027 67
FIG. 32 Australia Wearable Injectors Market, 2015-2027 68
FIG. 33 South  Korea Wearable Injectors Market, 2015-2027 69
FIG. 34 South-East Asia Wearable Injectors Market, 2015-2027 70
FIG. 35 Rest of Asia Pacific Wearable Injectors Market, 2015-2027 71
FIG. 36 Latin America Wearable Injectors Market, 2015-2027 72
FIG. 37 Brazil Wearable Injectors Market, 2015-2027 77
FIG. 38 Argentina Wearable Injectors Market, 2015-2027 78
FIG. 39 Rest of Latin America Wearable Injectors Market, 2015-2027 79
FIG. 40 The Middle-East and Africa Wearable Injectors Market, 2015-2027 80
FIG. 41 Saudi Arabia Wearable Injectors Market, 2015-2027 85
FIG. 42 UAE Wearable Injectors Market, 2015-2027 86
FIG. 43 Egypt Wearable Injectors Market, 2015-2027 87
FIG. 44 Kuwait Wearable Injectors Market, 2015-2027 88
FIG. 45 South Africa Wearable Injectors Market, 2015-2027 89
FIG. 46 Rest of Middle-East Africa Wearable Injectors Market, 2015-2027 90
FIG. 47 Competitor Market Share – Revenue 91
FIG. 48 Amgen Revenue and Growth Rate 96
FIG. 49 Amgen Market Share 96
FIG. 50 Becton Revenue and Growth Rate 98
FIG. 51 Becton Market Share 98
FIG. 52 Dickinson and Company Revenue and Growth Rate 100
FIG. 53 Dickinson and Company Market Share 100
FIG. 54 United Therapeutics Corporation Revenue and Growth Rate 102
FIG. 55 United Therapeutics Corporation Market Share 102
FIG. 56 Steadymed Therapeutics Revenue and Growth Rate 104
FIG. 57 Steadymed Therapeutics Market Share 104
FIG. 58 Tandem Diabetes Care Inc. Revenue and Growth Rate 106
FIG. 59 Tandem Diabetes Care Inc. Market Share 106
FIG. 60 Medtronic PLC Revenue and Growth Rate 108
FIG. 61 Medtronic PLC Market Share 108
FIG. 62 Valeritas Inc. Revenue and Growth Rate 110
FIG. 63 Valeritas Inc. Market Share 110
FIG. 64 Insulet Corporation Revenue and Growth Rate 112
FIG. 65 Insulet Corporation Market Share 112
FIG. 66 Ypsomed Revenue and Growth Rate 114
FIG. 67 Ypsomed Market Share 114
FIG. 68 Enable Injections Revenue and Growth Rate 116
FIG. 69 Enable Injections Market Share 116
FIG. 70 Sensile Medical Revenue and Growth Rate 118
FIG. 71 Sensile Medical Market Share 118
FIG. 72 Market Dynamics 120
FIG. 73 Global Wearable Injectors – Value Chain Analysis 123
FIG. 74 Technology Roadmap and Timeline 124
FIG. 75 Market Attractiveness Analysis – By Type 125
FIG. 76 Market Attractiveness Analysis – By Therapeutic Application 126
FIG. 77 Market Attractiveness Analysis – By End-User 126
FIG. 78 Market Attractiveness Analysis – By Region 128
FIG. 79 Market Channel 129
FIG. 80 Marketing Channel Development Trend 130
FIG. 81 Growth in World Gross Product, 2008-2018 131

List of Tables

TABLE 1 Global Wearable Injectors Market, 2018 & 2025 (USD Million) 21
TABLE 2 Global Wearable Injectors market, by Type, 2015-2027 (USD Million) 24
TABLE 3 Global Wearable Injectors market, by Therapeutic Application, 2015-2027 (USD Million) 28
TABLE 4 Global Wearable Injectors market, by End-User, 2015-2027 (USD Million) 32
TABLE 5 Global Wearable Injectors market, by Region, 2015-2027 (USD Million) 36
TABLE 6 North America Wearable Injectors Market, by Type, 2015-2027 (USD Million) 40
TABLE 7 North America Wearable Injectors Market, by Therapeutic Application, 2015-2027 (USD Million) 41
TABLE 8 North America Wearable Injectors Market, by End-User, 2015-2027 (USD Million) 42
TABLE 9 Europe Wearable Injectors Market, by Type, 2015-2027 (USD Million) 48
TABLE 10 Europe Wearable Injectors Market, by Therapeutic Application, 2015-2027 (USD Million) 49
TABLE 11 Europe Wearable Injectors Market, by End-User, 2015-2027 (USD Million) 50
TABLE 12 Asia Pacific Wearable Injectors Market, by Type, 2015-2027 (USD Million) 61
TABLE 13 Asia Pacific Wearable Injectors Market, by Therapeutic Application, 2015-2027 (USD Million) 62
TABLE 14 Asia Pacific Wearable Injectors Market, by End-User, 2015-2027 (USD Million) 63
TABLE 15 Latin America Wearable Injectors Market, by Type, 2015-2027 (USD Million) 74
TABLE 16 Latin America Wearable Injectors Market, by Therapeutic Application, 2015-2027 (USD Million) 75
TABLE 17 Latin America Wearable Injectors Market, by End-User, 2015-2027 (USD Million) 76
TABLE 18 The Middle-East and Africa Wearable Injectors Market, by Type, 2015-2027 (USD Million) 82
TABLE 19 The Middle-East and Africa Wearable Injectors Market, by Therapeutic Application, 2015-2027 (USD Million) 83
TABLE 20 The Middle-East and Africa Wearable Injectors Market, by End-User, 2015-2027 (USD Million) 84
TABLE 21 Global Wearable Injectors Market - Company Revenue Analysis 2015-2018 (USD Million) 91
TABLE 22 Global Wearable Injectors Market - Company Revenue Share Analysis 2015-2018 (%) 93
TABLE 23 Acquisitions and Mergers 94
TABLE 24 New Product/Service Launch 94
TABLE 25 Research & Development Activities 94
TABLE 26 Market Drivers 121
TABLE 27 Market Restraints 121
TABLE 28 Market Opportunities 122

Industry Major Market Players

  • Amgen, 
  • Becton, 
  • Dickinson Company, 
  • United Therapeutics Corporation, 
  • Steadymed Therapeutics, 
  • Tandem Diabetes Care Inc., 
  • Medtronic PLC, 
  • Valeritas Inc., 
  • Insulet Corporation, 
  • Ypsomed, 
  • Enable Injections, 
  • Sensile Medical

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying
have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions